【Bryan】評論
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG.與紅黴素並用時TDP發生率增加
【Bryan】評論
antipneumococcal fluoroquinolone 用於治療心律不整 於fluoroquinolone中覺容易引起TDP
【Bryan】評論
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG.與紅黴素並用時TDP發生率增加
【Bryan】評論
antipneumococcal fluoroquinolone 用於治療心律不整 於fluoroquinolone中覺容易引起TDP
【Bryan】評論
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG.與紅黴素並用時TDP發生率增加
【Bryan】評論
antipneumococcal fluoroquinolone 用於治療心律不整 於fluoroquinolone中覺容易引起TDP